Syncom Formulations (India) Limited (NSE:SYNCOMF)

India · Delayed Price · Currency is INR

13.09

-0.50 (-3.68%)

Feb 19, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals Drugs & Formulations	4.70B	2.62B	2.10B	2.20B	2.19B
Pharmaceuticals Drugs & Formulations Growth	79.37%	24.86%	-4.36%	0.30%	36.83%
Trading of Commodities	82.58M	107.13M	255.24M	94.23M	302.74M
Trading of Commodities Growth	-22.92%	-58.03%	170.86%	-68.87%	-36.16%
Renting of Property	39.15M	40.19M	33.53M	26.86M	27.92M
Renting of Property Growth	-2.59%	19.87%	24.85%	-3.80%	-16.42%
Total	4.82B	2.77B	2.39B	2.32B	2.52B
Total Growth	74.22%	15.93%	3.11%	-8.05%	19.56%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Export	3.80B	1.77B	1.44B	1.55B	1.78B
Export Growth	115.43%	22.59%	-7.08%	-12.76%	31.42%
India	751.11M	782.94M	788.12M	627.88M	616.14M
India Growth	-4.06%	-0.66%	25.52%	1.91%	-5.01%
Unallocated	72.68M	34.57M	17.68M	18.39M	54.89M
Unallocated Growth	110.26%	95.49%	-3.83%	-66.50%	1.01%
Total	4.63B	2.58B	2.25B	2.20B	2.45B
Total Growth	79.15%	15.01%	2.27%	-10.27%	19.12%

Source: S&P Global Market Intelligence.